Prolung Inc (FRES) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Prolung Inc   (FRES)


Prolung Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prolung Inc's ROI in the first quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Prolung Inc 's return on investment (ROI) in its first quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -14 -13 -12 -12 -11
Return On Investment (TTM) - - - - -
FRES's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -4 -5 -5 -5

FRES Company Profile >> Back to FRES Roi Comparisons >> See Annual FRES Return On Investment



Return On Investment FRES's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Prolung Inc's I. Quarter Investments $ -14 Millions FRES's Balance sheet
Prolung Inc's I. Quarter Income $ -1 Millions Quarterly FRES's Income Statement
FRES's Income by Division See FRES's Income by Division


FRES Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -13 -12 -1 -2 0
Y / Y Investment Growth - - - - -
Net Income in Millions -4 -4 -3 -5 -8
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FRES's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FRES's Competitors
Subscribers only: Roi for Prolung Inc's Suppliers
Subscribers only: Return On Investment for FRES's Customers

Other Ratios
FRES's Roa FRES's Inventory Turnover Ratio FRES's Growth Rates FRES's Dividend Statistics
FRES's Profitability Ratios FRES's Asset Turnover Ratio FRES's Dividend Growth
FRES's Roe FRES's Valuation Ratios FRES's Financial Strength Ratios FRES's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Revelation Biosciences Inc   67.96 %
Aptevo Therapeutics Inc   67.03 %
Voyager Therapeutics Inc   65.64 %
Opus Genetics Inc   65.61 %
Intercept Pharmaceuticals inc   63.41 %
Biomx Inc  60.93 %
Kiniksa Pharmaceuticals International Plc  56.13 %
Dariohealth Corp   54.64 %
Shockwave Medical Inc   48.20 %
Idexx Laboratories Inc  44.27 %
Fuse Medical Inc   43.08 %
Zymeworks Inc   42.67 %
Medpace Holdings Inc   40.11 %
Vaso Corporation  40.00 %
Arcturus Therapeutics Holdings Inc   38.17 %
Mettler toledo International Inc   35.59 %
Assertio Holdings inc   35.55 %
Harmony Biosciences Holdings inc   34.42 %
Catalyst Pharmaceuticals Inc   33.05 %
Nrc Health  31.34 %
Dynavax Technologies Corporation  29.65 %
Semler Scientific inc   28.96 %
Oncotelic Therapeutics Inc   27.82 %
Point Biopharma Global Inc   26.11 %
Moderna Inc   23.91 %
Vertex Pharmaceuticals Inc  22.30 %
Siga Technologies Inc  20.24 %
Innoviva Inc   20.18 %
Pro dex Inc   19.98 %
Chemed Corporation  19.95 %

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.